CNTX vs MTB · $55.1M cap vs P/E 12, rev $1.66B
Context Therapeutics Inc (CNTX) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Context Therapeutics Inc (CNTX) is a biotechnology company listed on NASDAQ.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
CNTX does not have a complete income-statement cache yet.
Latest reported MTB revenue for 2025-12-31 was $1.66B. Net income was $2.85B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
CNTX currently screens at market cap $55.1M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the CNTX and MTB stock pages for the full models.
Not investment advice.